Breakthrough findings demonstrate a possible target and potential drug treatment to restore memory loss and extend life span in mice with neurodegeneration
“We have treated mice with a new type of drug, and found that these drugs can not only improve symptoms of brain degeneration, such as cognitive decline, but can also extend the life-span of these terminally-sick mice. Our study opens up avenues for researchers to look at new drugs that treat the symptoms of Alzheimer’s and also slow disease progression”
– Professor Andrew Tobin
An international team of scientists has announced a new advance in the fight against Alzheimer’s disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
The four-year study by Medical Research Council (MRC) scientists based at the MRC Toxicology Unit at the University of Leicester is published in the Journal of Clinical Investigation. The study was led by Professor Andrew Tobin alongside colleagues from pharmaceutical company Eli Lilly and Company and the Monash Institute for Pharmaceutical Sciences in Australia. The project was also partly supported by the Wellcome Trust.
Corresponding author Professor Tobin, who alongside the lead researcher Dr Sophie Bradley has since moved from the University of Leicester to the University of Glasgow, said: “The paper describes drug-like molecules that can restore memory loss and slow progression of prion neurodegenerative disease in a manner that relates to the potential of these drugs in human Alzheimer’s disease.
“We have been using mice whose brain cells are progressively dying, similar to what happens in Alzheimer’s disease. This project focuses on a particular protein in the brain, which is proposed to be involved in Alzheimer’s disease, and as such could be a potential target for new drugs.
“We have treated mice with a new class of drug, and found that these drugs can not only improve symptoms of brain degeneration, such as cognitive decline, but can also extend the life-span of these terminally-sick mice.”
The researchers state that drugs which activate this protein receptor in the brain have previously been tested in clinical trials for Alzheimer’s disease, and showed positive results with respect to improving cognition, but the patients experienced a large number of adverse side effects. This new class of drug is more selective and does not cause any side-effects when administered to mice in the study.
The study authors believe that this offers hope in the design of new drugs for improving cognition and extending life span.
Professor Tobin said: “This work may provide important information as to whether this protein is a viable drug target in the treatment of diseases associated with the progressive death of brain cells. This is of great importance to society, based on the fact that the treatment options for Alzheimer’s disease are very limited – there are no cures for Alzheimer’s disease and current treatments are focused on relieving some of the symptoms.
“What we have found is a novel class of drugs, called allosteric ligands, that target a protein called the M1 muscarinic receptor, which is present in the brain. Activating this receptor protein can not only improve cognitive function in mice with progressive brain degeneration, but when administered daily, can extend life span.”
The scientists say the work is important because it focuses on identifying a treatment that not only improves symptoms associated with neurodegeneration, like current treatments, but also identifies a new strategy for slowing disease progression and extending life-span.
Professor Tobin said: “Alzheimer’s disease is the most common form of dementia, and it affects an estimated 850,000 people in the UK alone. There are no treatments that can slow or halt the progression of Alzheimer’s, and patients are treated with drugs which temporarily mask the symptoms of the disease. Often these treatments are associated with side-effects which can limit patient compliance.
“I am proud to be involved in a collaboration with researchers across the world to address one of the world’s major healthcare challenges. Our study opens up avenues for researchers to look at new drugs that treat the symptoms of Alzheimer’s and also slow disease progression.”
Receive an email update when we add a new ALZHEIMERS article.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Know the signs of Alzheimers slatedon January 9, 2020 at 2:30 pm
JOHNSTOWN –HealthLink Littauer, the community health and wellness service of Nathan Littauer Hospital and Nursing Home, announced a program on Alzheimer’s — Know The 10 Signs — will be held on ...
- Alzheimers Therapeutic Market Witness Rapid Development During the Period 2019- 2026on January 8, 2020 at 11:07 pm
As the competition soars in the global Alzheimers Therapeutic market, an increasing number of companies are looking exclusive insights into the prevailing trends in the market. Ameco Research study on ...
- Elaine's Hope: Former Governor Schreiber helping those with Alzheimerson January 8, 2020 at 5:25 pm
WAUWATOSA — It's an insidious disease that steals the life of so many entering their golden years. Former Governor Marty Schreiber knows that all too well - his wife Elaine has Alzheimer's. While ...
- Alzheon Announces Appointments of Noel Dunn, Jordan Heller, and Diane Jorkasky, MD, to Board of Directorson January 7, 2020 at 3:00 am
Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimers disease (AD) and other neurodegenerative disorders, announced today ...
- Silver Alert issued for missing Wichita man with Alzheimerson January 6, 2020 at 12:44 pm
Wichita police are asking for the public's help in locating a missing 68-year-old man who suffers from Alzheimers and dementia.
- Alzheimers Coachella Valley brings dementia expert Teepa Snow to lecture in deserton January 3, 2020 at 8:01 am
Organized by Alzheimers Coachella Valley, the afternoon talk on Sunday, Dec. 15, drew scores of people to UC Riverside’s Palm Desert campus.
- Alzheimers can be predicted BEFORE symptoms show as new test detects spread in brainon January 2, 2020 at 6:23 am
But a new study carried out by the University of California in San Francisco could change that, as scientists identify “key driver” of Alzheimers. Cutting-edge brain scans enable experts to track a ...
- Alzheimers' disease could be spotted years in advance, research suggestson January 1, 2020 at 10:00 am
Brain scans could diagnose Alzheimer's disease years before symptoms develop, research suggests. The new study found that a protein predicting the onset of the condition can be spotted on average 15 ...
- New DHS program uses music to combat Alzheimerson December 27, 2019 at 4:00 pm
MADISON, Wis. — Wisconsin Department of Health Services announced that 100 nursing homes around the state have been certified to take part in a new project that uses personalized music to assist ...
via Bing News